BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Usui T, Zhao J, Fuller DS, Hanafusa N, Hasegawa T, Fujino H, Nomura T, Zee J, Young E, Robinson BM, Nangaku M. Association of erythropoietin resistance and fibroblast growth factor 23 in dialysis patients: Results from the Japanese Dialysis Outcomes and Practice Patterns Study. Nephrology (Carlton) 2021;26:46-53. [PMID: 32743932 DOI: 10.1111/nep.13765] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Usui T, Zhao J, Fuller DS, Hanafusa N, Hasegawa T, Fujino H, Nomura T, Zee J, Young E, Robinson BM, Nangaku M. Association of erythropoietin resistance and fibroblast growth factor 23 in dialysis patients: Results from the Japanese Dialysis Outcomes and Practice Patterns Study. Nephrology (Carlton) 2021;26:46-53. [PMID: 32743932 DOI: 10.1111/nep.13765] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Weir MR. Managing Anemia across the Stages of Kidney Disease in Those Hyporesponsive to Erythropoiesis-Stimulating Agents. Am J Nephrol 2021;52:450-66. [PMID: 34280923 DOI: 10.1159/000516901] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]